Abstract
When treating mentally ill criminal offenders, improving medication adherence is essential to achieving goals, such as long-term stabilization of symptoms and the prevention of recidivism. Most subjects who are treated under the Medical Treatment and Supervision Act have schizophrenia, which is considered a particularly difficult disorder for which to improve medication adherence. For such patients, we developed a Medication Discontinuation Program (MDP) that aims to improve medication adherence by discontinuing antipsychotic drugs and monitoring changes in psychiatric symptoms. We examined whether there was any utility for the MDP on a trial basis as well as whether it would be worthwhile to introduce the MDP to psychiatric programs. We conducted the MDP with an intervention group (n = 7) and compared Drug Attitude Inventory-30 (DAI-30) scores before and after implementation of the MDP. We also categorized 30 questions of the DAI-30 into three subscales: "awareness of the need for medication", "awareness of the effects of psychiatric drugs", and "impression of medication", and examined factors affecting improvement in medication adherence. The total DAI-30 score significantly increased after completion of the MDP (P = 0.002). ...Continue Reading
References
Mar 1, 1990·Archives of General Psychiatry·A F Frank, J G Gunderson
Jan 1, 1991·Schizophrenia Bulletin·S J BartelsD H Freeman
Feb 1, 1983·Psychological Medicine·T P HoganR Eastwood
Oct 1, 1994·Archives of General Psychiatry·X F AmadorJ M Gorman
Feb 1, 1997·Social Psychiatry and Psychiatric Epidemiology·C NageotteP L Camp
Jan 1, 1997·Psychiatric Services : a Journal of the American Psychiatric Association·S M RuscherD Mazmanian
Jan 1, 1997·Schizophrenia Bulletin·W S FentonR K Heinssen
Feb 7, 2001·Schizophrenia Bulletin·M F GreenJ Mintz
Jun 20, 2001·The Journal of Clinical Psychiatry·M F GrunebaumM Olfson
Nov 6, 2002·The Journal of Clinical Psychiatry·Jonathan P LacroDilip V Jeste
Apr 16, 2003·Schizophrenia Bulletin·Kim A WeissJonathan D Huppert
Aug 16, 2003·Journal of Clinical Psychopharmacology·Christian R DolderDilip V Jeste
Dec 9, 2003·The Journal of Clinical Psychiatry·Samuel J Keith, John M Kane
May 4, 2007·The Journal of Clinical Psychiatry·Gunnar MorkenJan H Widen
Nov 13, 2009·International Journal of Law and Psychiatry·Yoji NakataniIsao Takayanagi